Beeline Medicines

Beeline Medicines is a clinical-stage biotechnology company focused on developing and delivering category-leading precision therapies.

Health and bio

TIMELINE · MONEY RAISED

Beeline Medicines | 70 days from website to first raise on record

Raised $726M in 2 sourced rounds·1 signal before the first raise

Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.

Funding rounds

1. July 6, 2026
   Series A · $426.3M
   BBain Capital, BBristol-Myers Squibb, CCPP Investments
   Source: Pulse 2.0
2. April 16, 2026
   Series A · $300M
   BBain Capital (lead)
   Source: Pulse 2.0
3. February 5, 2026
   Website created

Team

• SI
  Saqib Islam CEO
• FB
  Frédéric Baribaud Executive Director
• KP
  Kristin Patterson CTOO
• BE
  Badreddin Edris COO & President
• DP
  Daniel Pichl CPO
• NF
  Nathalie Franchimont CMO

Investors

• BBain Capitallead investor
• BBristol-Myers Squibb
• CCPP Investments

Companies like Beeline Medicines

• CComplement TherapeuticsSeries A · Apr 2023
• CCoultreon$125M Series A · Apr 2026
• IIDRx$120M Series B+ · Aug 2024
• VVaderis Therapeutics$152M Series B+ · Aug 2026
• SStorm Therapeutics$56M Series B+ · Apr 2026
• IInnornaSeries B+ · Apr 2022

Other companies backed by Bain Capital

• CCapGrid$4.87M Series B+ · Oct 2026
• LLegora$50M Series B+ · May 2026
• GGovini$150M Series B+ · Oct 2025
• SSdui$70M Series B+ · Jul 2025
• EEvenUpSeries B+ · Jul 2026
• AAnde

Bain Capital portfolio →